MAPrc PhD student Elizabeth Thomas with her baby daughter |
6 Sept 2018
Photo of the week: Motherhood and scholarship
What's on at CCS 10-14 September 2018
Dr Carolyn Breadon, PhD candidate at MAPrc,11.30 am Mon 10 Sep |
CCS staff and students can see details of both public and local events (including professional development courses, trade fairs and Graduate Research Student calendars) and deadlines, at the CCS intranet's Announcements page.
See CCS seminar index: www.monash.edu/medicine/ccs/headlines/events-calendar
What's on at CCS 10-14 September 2018
Mon | 10/09/2018 | ► | 11:30 | PhD confirmation milestone - Carolyn Breadon |
► | 12:00 | Neuroscience seminar series CANCELLED | ||
Tue | 11/09/2018 | ► | 11:00 | MPhil Confirmation Milestone: Ing Tiong |
Wed | 12/09/2018 | ► | 11:30 | Seminar: Christina Begka |
Thur | 13/09/2018 | ► | 11:30 | Journal Club: Jade Jaffar |
12:00 | Alfred Grand Rounds: Controversies in aged care |
Save the date! 12 November 2018 CCS graduate research symposium
You are invited to attend a symposium held by, and for, PhD and Masters students at the Central Clinical School’s 2018 Annual Graduate Research Symposium - the 11th in the annual series - and be a part of the most interactive, student run event of the year.
Join us for a variety of presentations from postgraduate students around Central Clinical School.
Recent CCS publications: 1 - 7 September 2018
ACBD research group working on leukaemia stem cells. L-R: Ms Loretta Cerruti, A/Prof Stephen Ting, Ms Jacqueline Boyle, A/Prof David Curtis, Dr Cedric Tremblay, Dr Stefan Sonderegger, Dr Emma Toulmin, Dr Christina Tebartz, Ms Jesslyn Saw, Mr Andrej Terzic, Ms Michelle Karlik, Ms Ashlee Conway. The bolded names are co-authors on a recent paper investigating pre-leukaemia stem cell mutations. Cure rates for acute leukemia have not improved over the last 20 years. One explanation for this lack of progress is the existence of rare leukemic cells that escape chemotherapy. Using genetically modified mice that can track cells according to their cycling kinetics, we found that dormant leukemic cells are essential for the progression of the disease. Most importantly, we show that these dormant cells escape chemotherapy and lead to recurrence of the disease in acute leukemia. This work will identify new ways to eliminate these therapy-resistant cells and improve cure rates for patients with acute leukemia. |
Scientists reveal reason why diabetes protects against aneurysms
Three of the study's authors: L-R Dr Tieqao Wu, Dr Zhong-Lin Chai and Dr Pacific Huynh |
For some years clinicians have observed that people with diabetes are usually less likely to have aortic aneurysms than non-diabetic patients. Aortic aneurysm is a major cause of death in older adults.
The phenomenon was puzzling: diabetes is associated with an increased incidence of cardiovascular disease, specifically related to atherosclerosis, hardening of the arteries. Most aortic aneurysms are caused by atherosclerosis, which weakens the blood vessel walls.
Now, Monash University scientists led by Dr Zhong-Lin Chai from the Department of Diabetes have revealed a mechanism that explains the phenomenon.
5 Sept 2018
International collaboration to investigate diabetes epigenetics
The Sagol Center for Epigenetics of Metabolism and Aging cements the relationship between Monash University and the Tel Aviv Medical Center, Israel’s largest health institution, where the centre will be based. The initiative was made possible by the generosity of the Sagol family in Israel and is the vision of philanthropist Sami Sagol.
Understanding type 2 diabetes: An ABC interview with Professor Merlin Thomas.
Professor Merlin Thomas |
This is how Merlin Thomas, a physician scientist from Monash University, begins when asked to explain how type 2 diabetes works.
Dr Elspeth Hutton: The burden of the 'suicide' headache
Dr Elspeth Hutton, Research Fellow Department of Neuroscience |
Commonly known as cluster headaches, they can occur up to eight times a day. They start suddenly, last for up to three hours, and can be very painful. A bout of regular attacks, known as a cluster bout, can last weeks to months.
3 Sept 2018
2018 AMREP EMCR symposium 14 Sept deadline for abstract submission
Dr Glenn Begley at the 2017 CCS hosted Translational Research symposium. Glenn is noted for his lively presentations. |
We also have two really amazing keynote speakers who are taking time out of their busy schedules to speak to us, as well as a career development panel who will answer all of your questions about how to make the most of your CV and interview opportunities.
We encourage all EMCRs and final year PhD students to attend, though early PhD students are welcome to register also. Please register for catering purposes.
Participants sought: Migraine and visual disturbance, known as 'visual snow'
Visual snow can granulate visual perception as per the right-hand image pictured here. Image: Medpage today |
Currently, there is little understanding of the causes of Visual Snow (VS) and the relationship between VS and migraine. As such, more research needs to be conducted to better understand the underlying mechanisms of these conditions.
A large portion of the brain is involved in vision and controlling the movement of the eyes. Other research has shown that simple eye movement tests and visual perception tasks can give important information about the mechanisms underlying neurological conditions.
What we want to find out
We wish to investigate whether differences in performance on eye movement and visual perception tests can account for the symptoms of VS and the differences in symptomology between VS and migraine.
Participants sought: Synchronising brain rhythms with mild electrical stimulation
Neural activity patterns. Wikipedia |
Participation will involve visiting our research centre in Prahran for three sessions. In each session you will undergo a short session of non-invasive brain stimulation and we will ask you questions about your experience of the stimulation and also record your brain activity. Each session will take between 2-3 hours to complete. You will be compensated $20 per session.
If you would like more details or might be interested in participating, please contact Dr Aron Hill, email aron.hill@monash.edu
See more detail at:
https://ccs-clin-trials.med.monash.edu.au/trials/equivalence-and-stimulation-parameter-investigations-brainamp-stimeegv2b-purpose-developed-tr
Subscribe to:
Posts (Atom)